Talphera (TLPH) EBITDA Margin Growth (1y) (2012 - 2023)
Talphera (TLPH) EBITDA Margin Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 304.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -157.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,330.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -650.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,630.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,962.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 111.00 |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 199,315.00 |
| Mar 31, 2022 | -24,603.00 |
| Dec 31, 2021 | -40.75 Mn |
| Sep 30, 2021 | 15,278.00 |
| Jun 30, 2021 | -202,700.00 |
| Mar 31, 2021 | 231,666.00 |
| Dec 31, 2020 | 190,364.00 |
| Sep 30, 2020 | 156,539.00 |
| Jun 30, 2020 | 118,615.00 |
| Mar 31, 2020 | 54,260.00 |
| Dec 31, 2019 | -136,551.00 |
| Sep 30, 2019 | 24,828.00 |
| Jun 30, 2019 | -54,542.00 |
| Mar 31, 2019 | -223,751.00 |
| Dec 31, 2018 | -73,570.00 |
| Sep 30, 2018 | -187,837.00 |
| Jun 30, 2018 | -50,059.00 |
| Mar 31, 2018 | -202,246.00 |
| Dec 31, 2017 | -94,408.00 |
| Sep 30, 2017 | -35,897.00 |